Navigation Links
Chemotherapy Pill Has Fewer Side Effects Than IV,,

A chemotherapy pill is as effective for treating advanced colorectal cancer as intravenous treatment with a similar drug. Patients taking the pill capecitabine survived just as long as those on standard chemotherapy, but the pill caused fewer side effects.// Capecitabine is the oral form of 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to treat advanced colorectal cancer.

Capecitabine is both convenient to use and produces fewer side effects, and that's a big attraction for patients. Given these results, patients slated to receive the chemotherapy drug 5-FU could consider receiving it in pill form rather than through an IV.

Capecitabine, sold as Xeloda by New Jersey-based Roche Laboratories, has been approved by the FDA to treat breast cancer that has spread beyond the breast and is resistant to standard chemotherapy. Unlike intravenous 5-FU, which is active throughout the body, capecitabine is designed to target tumor cells directly.

Patients taking the oral drug were significantly more likely to respond to treatment than those on standard chemotherapy, and side effects, including diarrhoea, hair loss, nausea and gastrointestinal tract ulcers, were less common in patients taking the pill, particularly during the first few months of treatment. Patients in the capecitabine group were also less likely to be hospitalized due to side effects.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
3. Therapy Boosts Chemotherapy Effects
4. Chemotherapy Effective for Bladder Cancer
5. New Method Of Delivering Chemotherapy
6. The Benefits Of Chemotherapy For Women With Ovarian Cancer
7. New Compound Could Strengthen The Effect Of Chemotherapy
8. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
9. Treating Testicular Cancer With A Single Dose Of Chemotherapy
10. Ginger Found To Reduce Nausea Associated With Chemotherapy
11. AIDS Drug Found To Help Patients Undergoing Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: